Medical and patients knowledge of SNAIDs digestive complications nisks;Connaissance par les médecins et les patients du risque de complications digestives des AINS

Presse Medicale

Volumn 32, Issue 37 II, 2003, Pages

  Flipo, René Marc ^a   Bertin, Philippe ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

CHEMOPROPHYLAXIS; DRUG INFORMATION; DYSPEPSIA; FATALITY; GASTRODUODENAL ULCER; HUMAN; PRESCRIPTION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0345303840     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Kahn MF. L'information du patient. in: L'actualité Rhumatologique 2000, Paris, Expansion Scientifique Française, pp 423-31.
2. Agence nationale d'accréditation et d'évaluation en santé. Recommandations pour la pratique clinique. Information des patients - Recommandations destinées aux médecins. Mars 2000
3. Woolf AJ, Frolich JC, Martin-Mola E. Inconsistencies in the primary care management of osteoarthritis in three European countries. Ann Rheum Dis 2002; 61 (Suppl 1): 125.
4. Bakowsky VS, Hanly JG. Complications of nonsteroidal antiinflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center. J Rheumatol 1999; 26: 1557-63.
5. Smalley W, Stein CM, Arbogast PG, Eisen G, Ray WA, Griffin M. Underutilization of gastroprotective measures in patients receiving non steroidal antiinflammatory drugs. Arthritis Rheum 2002; 46: 2195-200.
6. Montano Alonso A, Torello Iserte J, Castillo Ferrando JR, Cayuela Dominguez A, Moreno Gallego I, Fernandez Diez P. Users' attitude and information about use of NSAID intervention study. Aten Primera 1997; 20: 114-20.
7. Wynne HA, Long A. Patient awareness of the adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs). Br J Clin Pharmacol 1996; 42: 253-6.
8. Herxheimer A. Many NSAID users who bleed don't know when to stop. Uncomprehending "adherence" is dangerous. BMJ 1998; 316: 492.
9. Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol 1999; 2S (Suppl 26): 18-24.
10. Berthelot JM, Millet S, Chatelier B, Ripoll N, Maugars Y, Prost A. Connaissance par 125 patients des règles de prise de leur anti-inflammatoire non stéroïdien. Thérapie 1999; 54: 683-8.
11. Gay A, Claudepierre P, Grardel B, Flipo RM. Spondylarthrite ankylosante et AINS: état de l'information des malades. Rev Rhum 2000; 67: 826-7.
12. Katz JN, Daltroy LH, Brennan TA, Liang MH. Informed consent and the prescription of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1992; 3S: 1257-66.
13. Bonnet C, Fradet E, Bertin P, Vergne P, Treves R. Influence de l'information médicale sur l'apparition d'effets secondaires symptomatiques lors de la prescription d'anti-inflammatoires non stéroïdiens. Rev Rhum 2000; 67: 730.
14. Goupille P, Logeart I, Combe B. Enquête naturaliste sur l'utilisation des anti-inflammatoires non stéroïdiens chez des patients souffrant de douleurs rhumatologiques. Rev rhum 2003; 70, 416-423.
15. Ratcliffe J, Buxton MJ, McGarry T, Sheldon R, Chancellor JVM. Patients' preferences for characteristics associated with treatments for osteoarthritis. Ann Rheum Dis 2002; 61 (Suppl 1): 33S.